A new venture capital for rare diseases

0

Chiesi Ventures in the new venture capital firm born from the strategic partnership between the Italian leading pharmaceutical company Chiesi Group and A.M. Pappas & Associates, a venture company fully dedicated to the life science business sector. Chiesi Ventures will focus its activities on the area of rare and orphan disorders through investments in early stage development opportunities in order to complement the strategy of Chiesi Group in the area. A. M. Pappas & Associates will provide expertise and network to access and assess deals and opportunities of investments to the newborn venture company, which will also support and accelerate the expansion of the Chiesi network in the US.

SHARE

LEAVE A REPLY

Please enter your comment!
Please enter your name here